Prepare your abstract for the Annual Meeting!

Abstract Submission Guidelines

All submissions must be fully submitted by the deadline. Deadlines are firm, and no exceptions will be made for late submissions.

Please note that invited speakers should not submit an abstract on their invited topic. Invited speakers will be prompted to submit their talk title and description through the speaker portal.

Our Late-Breaking Submission period is not intended for “late” abstracts but abstracts with groundbreaking data that was not available during the general call for submissions.

In 2025, Abstract Poster Sessions will occur on Tuesday, Wednesday, and Thursday.

Important Dates

General Requirements

• All abstracts must be submitted in clear and concise English. Spelling may be in US English or UK English.
• In most cases, Greek letters and other special characters will transfer from your word processing software via copy-and-paste functions.
• Remove all track changes before submitting your abstract; copy-and-paste functions can pick up these changes, making the abstract incoherent.
• The title should be entered exactly as it is to appear online—titles should be submitted in title case.
• The names of all co-authors and their institutional affiliations must be provided at the time of submission.
  • Any names excluded in submission will not be listed in the author block of the publication online or in the Journal.
• It is the responsibility of the submitter to proofread the abstract and author list carefully.
• Tables and figures may be uploaded via a photo file type.
• The abstract may be structured (i.e., divided into sections: introduction, methods, results, conclusions) or unstructured.
• Do not use bold or underline formatting—italic type is acceptable.
• The submitter may make changes to abstracts before the submission deadline closes.
  • Changes after the submission deadline but before the review has started must be sent to abstracts@asgct.org—all changes should include the tracking number and title of the abstract and explicitly say what changes need to be made. New authors must be listed in order and with their institutions, locations, and email addresses.
  • No changes will be made to any abstract after the review has started.

The presenting author of abstracts selected for oral or poster presentation must attend the Annual Meeting in person. If the original designated presenting author cannot attend, a co-author may be designated as an alternative presenter.

Plain Language Summaries

ASGCT wants to help ensure your research findings are more accessible to disease communities by offering the opportunity to submit an abstract summary using plain language. The summaries will be available for reference to those viewing abstracts, and some may also be shared with the disease community or through ASGCT communications. These submissions will not be used during the review process for abstract acceptance and will be under the same embargo policy as the abstracts.

Learn More about Plain Language Summaries

Late-Breaking Abstracts

Late-breaking abstracts (LBA) submissions are solely for abstracts with late-breaking data and are not for abstracts submitted “late.” The Late-breaking Abstracts deadline is not an extension of the general submission deadline. Late-breaking abstracts not chosen for the 14 open oral slots will not be accepted as posters or any other type of presentation or publication.

Applicants will be asked to answer the question: “What makes your abstract newsworthy, ground-breaking, or high-impact?”

Review and Selection

All abstracts are reviewed by a group of volunteer reviewers assigned to each category selected by the Secretary and Abstract Chair. Abstract reviewers consider several variables in rating the abstract for selection as an oral presentation. General considerations include the quality of the research and presentation, the strength of the results and methods, and whether the reported research significantly advances the field. The committees also reject submissions advertising a product or service or showing little scientific merit.

Each review committee is made up of 5-7 individuals from varying backgrounds who specialize in the category assigned. Upon review, they can submit suggested abstracts for the Presidential Symposium and the Clinical Trials Symposium. These abstracts are then further reviewed by our Abstract Advisory Group, which comprises the President, President-elect, Secretary, and a small group of reviewers of their choosing.

In the fall, the Abstract Advisory Group will decide on the abstract categories, and a call for abstract reviewers will follow.

Tips for Submitting the Best Abstract

• Clarity is vital.
• Choose your category wisely.
• Highlight new and novel aspects and be clear about your advancements.
• Clearly describe the model system(s) used.
• Avoid too many background details—get to the point.
• Edit and proofread your abstract—use English editing support if needed.

2025 Notification

• Abstract acceptance notifications will be emailed after all reviews are completed on March 31, 2025. If you don’t receive your notification email by April 2, 2025, please contact the Abstract inbox abstracts@asgct.org.  
• Accepted abstracts will be scheduled as either oral or poster presentations. 
• The official acceptance letter, which includes the presentation date, time, and location, will be posted on the abstract submission site. 
• International abstract submitters who plan to attend the 28th Annual Meeting must apply for a visa to travel to the meeting in New Orleans, Louisiana, USA.
  • Please note:  The time required to obtain a visa has increased tremendously. Abstract submitters will be able to generate invitation letters soon to apply for visas immediately after submitting an abstract. Please contact abstracts@asgct.org with any questions.

Contact Information

General questions on abstract submission policies or notifications should be emailed to abstracts@asgct.org.

ASGCT Annual Meeting registration, housing, membership, and login reset requests should be sent to info@asgct.org.